Clinical Trials in Los Angeles

Showing 601-620 of 14,465 trials

Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

NCT05018611

The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.

HIV Prevention

University of California, Los Angeles5,100 participantsStarted Jan 2022

Los Angeles, California, United States

Active Not RecruitingPhase 3< 1 mile

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

NCT06113471

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

NonSegmental Vitiligo

Incyte Corporation450 participantsStarted Nov 2023

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Fountain Valley, California, United States +83 more locations

Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

Find Trials by Condition in Los Angeles

An Observational Study of Individuals With Isolated Dystonia

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

Study of AV-1959D, an Amyloid Beta Vaccine

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)